N-Q 1 fp0034565_nq.htm

OMB APPROVAL

OMB Number: 3235-0578

 

Expires: March 31, 2019

 

Estimated average burden hours per response: 10.5


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM N-Q

 

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number 811-21120  

 

Conestoga Funds
(Exact name of registrant as specified in charter)

 

Conestoga Capital Advisors, 550 E. Swedesford Rd., Suite 120, Wayne, PA 19087
(Address of principal executive offices) (Zip code)

 

Conestoga Capital Advisors

550 E. Swedesford Rd., Suite 120, Wayne, PA 19087
(Name and address of agent for service)

 

With a copy to:

John Deringer, Esq., Drinker Biddle, One Logan Square, Suite 2000, Philadelphia, PA 19103

 

Registrant's telephone number, including area code: (800) 320-7790  

 

Date of fiscal year end: September 30  
     
Date of reporting period: June 30, 2018  

 

Form N-Q is to be used by management investment companies other than small business investment companies registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than 60 days after the close of the first and third fiscal quarters, pursuant to Rule 30b1-5 under the Investment Company Act of 1940 (17 CFR 270.30b1-5). The Commission may use the information provided on Form N-Q in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-Q, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-Q unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.

 

 

 

 

Item 1.Schedule of Investments.

 

CONESTOGA SMALL CAP FUND
SCHEDULE OF INVESTMENTS
June 30, 2018 (Unaudited)

 

COMMON STOCKS - 95.5%  Shares   Value 
Consumer Discretionary - 15.2%        
Auto Parts - 1.4%        
Dorman Products, Inc. (a)   470,949   $32,170,526 
           
Consumer Services: Miscellaneous - 4.9%          
Sotheby's (a)   936,180    50,872,021 
Stamps.com, Inc. (a)   232,700    58,884,735 
         109,756,756 
Education Services - 3.8%          
Grand Canyon Education, Inc. (a)   460,500    51,396,405 
HealthStream, Inc.   1,173,177    32,039,464 
         83,435,869 
Leisure Time - 2.9%          
Fox Factory Holding Corporation (a)   1,371,875    63,860,782 
           
Specialty Retail - 2.2%          
SiteOne Landscape Supply, Inc. (a)   568,800    47,762,136 
           
Consumer Staples - 5.0%          
Beverage: Brewers and Distillers - 2.1%          
MGP Ingredients, Inc.   539,284    47,893,812 
           
Foods - 1.0%          
Chefs' Warehouse, Inc. (The) (a)   804,906    22,939,821 
           
Personal Care - 1.9%          
WD-40 Company   283,350    41,439,938 
           
Energy - 1.0%          
Oil: Crude Producers - 1.0%          
Matador Resources Company (a)   732,006    21,996,780 
           
Financial Services - 1.4%          
Asset Management & Custodian - 1.4%          
Westwood Holdings Group, Inc. (b)   534,521    31,825,380 

 

 

 

 

CONESTOGA SMALL CAP FUND
SCHEDULE OF INVESTMENTS (Continued)

 

COMMON STOCKS - 95.5% (Continued)  Shares   Value 
Health Care - 19.3%        
Biotechnology - 5.9%        
Ligand Pharmaceuticals, Inc. (a)   357,325   $74,027,020 
Repligen Corporation (a)   1,203,000    56,589,120 
         130,616,140 
Health Care Management Services - 0.5%          
National Research Corporation   337,474    12,621,528 
           
Health Care Services - 4.8%          
Medidata Solutions, Inc. (a)   510,450    41,121,852 
Omnicell, Inc. (a)   1,254,950    65,822,128 
         106,943,980 
Medical and Dental Instruments & Supplies - 8.1%          
Bio-Techne Corporation   175,400    25,950,430 
Cantel Medical Corporation   479,942    47,207,095 
LeMaitre Vascular, Inc. (b)   1,010,299    33,824,810 
Neogen Corporation (a)   904,466    72,529,129 
         179,511,464 
Materials & Processing - 9.7%          
Building Materials - 5.6%          
Simpson Manufacturing Company, Inc.   999,900    62,183,781 
Trex Company, Inc. (a)   981,150    61,410,178 
         123,593,959 
Building: Climate Control - 2.1%          
AAON, Inc.   1,390,850    46,245,762 
           
Chemicals: Specialty - 2.0%          
Balchem Corporation   462,175    45,357,855 
           
Producer Durables - 20.2%          
Back Office Support, HR & Consulting - 2.9%          
WageWorks, Inc. (a)   1,280,491    64,024,550 
           
Engineering & Contracting Services - 3.1%          
Exponent, Inc.   1,406,400    67,929,120 

 

 

 

 

CONESTOGA SMALL CAP FUND
SCHEDULE OF INVESTMENTS (Continued)

 

COMMON STOCKS - 95.5% (Continued)  Shares   Value 
Producer Durables - 20.2% (Continued)        
Environmental, Maintenance & Security Services - 2.4%        
Healthcare Services Group, Inc.   878,900   $37,959,691 
Rollins, Inc.   287,700    15,127,266 
         53,086,957 
Machinery: Construction and Handling - 1.1%          
Douglas Dynamics, Inc.   534,485    25,655,280 
           
Machinery: Industrial - 4.1%          
EnviroStar, Inc.   277,122    11,168,017 
John Bean Technologies Corporation   319,450    28,399,105 
Proto Labs, Inc. (a)   432,075    51,395,321 
         90,962,443 
Scientific Instruments: Control & Filter - 3.7%          
ESCO Technologies, Inc.   692,700    39,968,790 
Sun Hydraulics Corporation   897,950    43,272,210 
         83,241,000 
Scientific Instruments: Gauges & Meters - 2.9%          
Mesa Laboratories, Inc. (b)   307,336    64,872,483 
           
Technology - 23.7%          
Computer Services Software & Systems - 18.3%          
ACI Worldwide, Inc. (a)   1,550,015    38,238,870 
Blackbaud, Inc.   508,600    52,106,070 
BlackLine, Inc. (a)   672,300    29,197,989 
Bottomline Technologies (de), Inc. (a)   1,417,700    70,643,991 
Descartes Systems Group, Inc. (The) (a)   2,051,775    66,682,687 
Mercury Systems, Inc. (a)   795,010    30,258,081 
NIC, Inc.   1,227,200    19,082,960 
PROS Holdings, Inc. (a)   1,440,700    52,686,399 
SPS Commerce, Inc. (a)   303,350    22,290,158 
Tyler Technologies, Inc. (a)   110,300    24,497,630 
         405,684,835 
Electronic Components - 3.2%          
NVE Corporation (b)   281,750    34,311,515 
Rogers Corporation (a)   335,495    37,394,273 
         71,705,788 

 

 

 

CONESTOGA SMALL CAP FUND
SCHEDULE OF INVESTMENTS (Continued)

 

COMMON STOCKS - 95.5% (Continued)  Shares   Value 
Technology - 23.7% (Continued)        
Production Technology Equipment - 0.7%        
Novanta, Inc. (a)   258,600   $16,110,780 
           
Telecommunications Equipment - 1.5%          
Vocera Communications, Inc. (a)   1,122,900    33,563,481 
           
Total Common Stocks (Cost $1,385,963,559)       $2,124,809,205 

 

MONEY MARKET FUNDS - 0.9%  Shares   Value 
Fidelity Investments Treasury Only Portfolio - Institutional Shares, 1.78% (c) (Cost $20,119,879)   20,119,879   $20,119,879 
           
Total Investments at Value - 96.4% (Cost $1,406,083,438)       $2,144,929,084 
           
Other Assets in Excess of Liabilities - 3.6%        79,409,211 
           
Net Assets - 100.0%       $2,224,338,295 

 

(a) Non-income producing security.
(b) The Fund owned 5% or more of the company’s outstanding voting shares thereby making the company an affiliate of the Fund as that term is defined in the Investment Company Act of 1940 (Note 5).
(c) The rate shown is the 7-day effective yield as of June 30, 2018.

 

See accompanying notes to Schedules of Investments.

 

 

 

CONESTOGA SMID CAP FUND
SCHEDULE OF INVESTMENTS
June 30, 2018 (Unaudited)

 

COMMON STOCKS - 95.6%  Shares   Value 
Consumer Discretionary - 12.9%        
Consumer Services: Miscellaneous - 1.4%        
Stamps.com, Inc. (a)   3,187   $806,470 
           
Educational Services - 3.3%          
Bright Horizons Family Solutions, Inc. (a)   18,575    1,904,309 
           
Leisure Time - 4.6%          
Pool Corporation   12,040    1,824,060 
Vail Resorts, Inc.   3,035    832,167 
         2,656,227 
Recreational Vehicles & Boats - 2.4%          
LCI Industries   6,420    578,763 
Polaris Industries, Inc.   6,860    838,155 
         1,416,918 
Specialty Retail - 1.2%          
SiteOne Landscape Supply, Inc. (a)   8,295    696,531 
           
Consumer Staples - 1.1%          
Foods - 1.1%          
Chefs' Warehouse, Inc. (The) (a)   21,750    619,875 
           
Energy - 1.0%          
Energy Equipment - 1.0%          
Core Laboratories N.V.   4,705    593,818 
           
Financial Services - 3.5%          
Financial Data & Systems - 2.1%          
Jack Henry & Associates, Inc.   9,375    1,222,125 
           
Insurance: Multi-Line - 1.4%          
Markel Corporation (a)   775    840,371 
           
Health Care - 20.1%          
Biotechnology - 3.2%          
Ligand Pharmaceuticals, Inc. (a)   4,630    959,197 

 

 

 

CONESTOGA SMID CAP FUND
SCHEDULE OF INVESTMENTS (Continued)

 

COMMON STOCKS - 95.6% (Continued)  Shares   Value 
Health Care - 20.1% (Continued)        
Biotechnology - 3.2% (Continued)        
Repligen Corporation (a)   19,475   $916,104 
         1,875,301 
Health Care Services - 5.2%          
Cotiviti Holdings, Inc. (a)   15,100    666,363 
Medidata Solutions, Inc. (a)   8,855    713,359 
Omnicell, Inc. (a)   31,475    1,650,863 
         3,030,585 
Medical and Dental Instruments & Supplies - 9.8%          
Align Technology, Inc. (a)   3,585    1,226,572 
Bio-Techne Corporation   6,540    967,593 
Cantel Medical Corporation   9,074    892,519 
Neogen Corporation (a)   9,548    765,654 
Teleflex, Inc.   3,135    840,838 
West Pharmaceutical Services, Inc.   9,964    989,326 
         5,682,502 
Medical Equipment - 1.9%          
IDEXX Laboratories, Inc. (a)   5,206    1,134,596 
           
Materials & Processing - 8.0%          
Building Materials - 5.4%          
Simpson Manufacturing Company, Inc.   13,310    827,749 
Trex Company, Inc. (a)   13,000    813,670 
Watsco, Inc.   8,275    1,475,267 
         3,116,686 
Building: Climate Control - 1.3%          
AAON, Inc.   23,400    778,050 
           
Chemicals: Specialty - 1.3%          
Balchem Corporation   7,825    767,945 
           
Producer Durables - 26.7%          
Aerospace - 2.5%          
HEICO Corporation - Class A   23,635    1,440,553 

 

 

 

CONESTOGA SMID CAP FUND
SCHEDULE OF INVESTMENTS (Continued)

 

COMMON STOCKS - 95.6% (Continued)  Shares   Value 
Producer Durables - 26.7% (Continued)        
Back Office Support, HR & Consulting - 8.2%        
Copart, Inc. (a)   27,760   $1,570,105 
CoStar Group, Inc. (a)   3,747    1,546,125 
WageWorks, Inc. (a)   33,395    1,669,750 
         4,785,980 
Engineering & Contracting Services - 1.4%          
Exponent, Inc.   17,290    835,107 
           
Environmental, Maintenance & Security Services - 4.8%          
Healthcare Services Group, Inc.   25,420    1,097,890 
Rollins, Inc.   32,050    1,685,189 
         2,783,079 
Machinery: Industrial - 3.6%          
EnviroStar, Inc.   18,265    736,080 
John Bean Technologies Corporation   8,685    772,097 
Proto Labs, Inc. (a)   5,035    598,913 
         2,107,090 
Machinery: Specialty - 1.7%          
Graco, Inc.   21,355    965,673 
           
Railroad Equipment - 1.9%          
Westinghouse Air Brake Technologies Corporation   11,155    1,099,660 
           
Scientific Instruments & Services - 1.4%          
A.O. Smith Corporation   13,815    817,157 
           
Scientific Instruments: Control & Filter - 1.2%          
Donaldson Company, Inc.   15,675    707,256 
           
Technology - 22.3%          
Computer Services Software & Systems - 20.0%          
ACI Worldwide, Inc. (a)   21,075    519,920 
ANSYS, Inc. (a)   8,325    1,450,049 
Blackbaud, Inc.   11,371    1,164,959 
Bottomline Technologies (de), Inc. (a)   13,650    680,180 
Descartes Systems Group, Inc. (The) (a)   29,450    957,125 

 

 

 

CONESTOGA SMID CAP FUND
SCHEDULE OF INVESTMENTS (Continued)

 

COMMON STOCKS - 95.6% (Continued)  Shares   Value 
Technology - 22.3% (Continued)        
Computer Services Software & Systems - 20.0% (Continued)        
Gartner, Inc. (a)   8,925   $1,186,133 
Guidewire Software, Inc. (a)   17,050    1,513,699 
Mercury Systems, Inc. (a)   27,105    1,031,616 
SPS Commerce, Inc. (a)   6,332    465,275 
Tyler Technologies, Inc. (a)   6,699    1,487,848 
Ultimate Software Group, Inc. (The) (a)   4,575    1,177,193 
         11,633,997 
Electronics - 1.2%          
IPG Photonics Corporation (a)   3,107    685,497 
           
Production Technology Equipment - 1.1%          
Cognex Corporation   15,215    678,741 
           
Total Common Stocks (Cost $42,494,766)       $55,682,099 

 

MONEY MARKET FUNDS - 0.4%  Shares   Value 
Fidelity Treasury Money Market Fund, 1.52% (b) (Cost $251,215)   251,215   $251,215 
           
Total Investments at Value - 96.0% (Cost $42,745,981)       $55,933,314 
           
Other Assets in Excess of Liabilities - 4.0%        2,305,324 
           
Net Assets - 100.0%       $58,238,638 

 

(a) Non-income producing security.
(b) The rate shown is the 7-day effective yield as of June 30, 2018.

 

See accompanying notes to Schedules of Investments.

 

 

 

CONESTOGA FUNDS

NOTES TO SCHEDULES OF INVESTMENTS

June 30, 2018 (Unaudited)

 

1.Securities Valuation

 

Conestoga Funds (the “Trust”) consists of two series, Conestoga Small Cap Fund and Conestoga SMid Cap Fund (individually, a “Fund” and collectively, the “Funds”). The Funds value their respective portfolio securities at market value as of the close of regular trading on the New York Stock Exchange (the “NYSE”) (normally 4:00 p.m. Eastern time) on each business day the NYSE is open for business. The Funds value their listed securities on the basis of the security’s last sale price on the security’s primary exchange, if available, otherwise at the exchange’s most recently quoted bid price. NASDAQ-listed securities are valued at the NASDAQ Official Closing Price. When using a quoted price and when the market is considered active, the security will be classified as Level 1 within the fair value hierarchy (see below). In the event that market quotations are not readily available or are considered unreliable due to market or other events, the Funds value their securities and other assets at fair value, as determined in good faith by and under the supervision of the Trust’s officers, in accordance with procedures established by and under the general supervision of the Board of Trustees of the Trust. Under these procedures, the securities will be classified as Level 2 or 3 within the fair value hierarchy, depending on the inputs used. Unavailable or unreliable market quotes may be due to the following factors: a substantial bid-ask spread; infrequent sales resulting in stale prices; insufficient trading volume; small trade sizes; a temporary lapse in any reliable pricing source; and actions of the securities or futures markets, such as the suspension or limitation of trading. As a result, the prices of securities used to calculate each Fund’s net asset value (“NAV”) may differ from quoted or published prices for the same securities.

 

Accounting principles generally accepted in the United States (“GAAP”) establish a single authoritative definition of fair value, set out a framework for measuring fair value and require additional disclosures about fair value measurements.

 

Various inputs are used in determining the value of the Funds’ investments. These inputs are summarized in the three broad levels listed below:

 

•Level 1 – quoted prices in active markets for identical securities
•Level 2 – other significant observable inputs
•Level 3 – significant unobservable inputs

 

The inputs or methods used for valuing securities are not necessarily an indication of the risks associated with investing in those securities. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety is determined based on the lowest level input that is significant to the fair value measurement.

 

The following is a summary of the inputs used to value the Funds’ investments as of June 30, 2018:

 

Conestoga Small Cap Fund  Level 1   Level 2   Level 3   Total 
                 
Common Stocks  $2,124,809,205   $-   $-   $2,124,809,205 
Money Market Funds   20,119,879    -    -    20,119,879 
   $2,144,929,084   $-   $-   $2,144,929,084 

 

 

Conestoga SMid Cap Fund  Level 1   Level 2   Level 3   Total 
                 
Common Stocks  $55,682,099   $-   $-   $55,682,099 
Money Market Funds   251,215    -    -    251,215 
   $55,933,314   $-   $-   $55,933,314 

 

 

 

 

 

CONESTOGA FUNDS

NOTES TO SCHEDULES OF INVESTMENTS (Continued)

 

Refer to each Fund’s Schedule of Investments for a listing of the common stocks by industry type. As of June 30, 2018, the Funds did not have any transfers between Levels. In addition, the Funds did not have any derivative instruments or assets or liabilities that were measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of June 30, 2018. It is the Funds’ policy to recognize transfers between Levels at the end of the reporting period.

 

2.Investment Transactions

 

Investment transactions are accounted for on trade date. Realized gains and losses on investments sold are determined on a specific identification basis.

 

3.Federal Income Tax

 

The following information is computed on a tax basis for each item as of June 30, 2018:

 

   Conestoga   Conestoga 
   Small Cap Fund   SMid Cap Fund 
         
Tax cost of portfolio investments  $1,407,717,244   $42,745,982 
           
Gross unrealized appreciation  $760,540,063   $13,910,339 
Gross unrealized depreciation   (23,328,223)   (723,007)
           
Net unrealized appreciation  $737,211,840   $13,187,332 

 

The difference between the federal income tax cost of portfolio investments and the Schedule of Investments cost for each Fund is due to certain timing differences in the recognition of capital gains and losses under income tax regulations and GAAP. These “book/tax” differences are temporary in nature and are due to the tax deferral of losses on wash sales.

 

4.Sector Risk

 

If a Fund has significant investments in the securities of issuers within a particular sector, any development affecting that sector will have a greater impact on the value of the net assets of the Fund than would be the case if the Fund did not have significant investments in that sector. In addition, this may increase the risk of loss in the Fund and increase the volatility of the Fund’s NAV per share. Occasionally, market conditions, regulatory changes or other developments may negatively impact a particular sector. As of June 30, 2018, Conestoga Small Cap Fund had 20.2% and 23.7% of the value of its net assets invested in stocks within the Producer Durables and Technology sectors, respectively, and Conestoga SMid Cap Fund had 20.1%, 26.7%, and 22.3% of the value of its net assets invested in stocks within the Health Care, Producer Durables, and Technology sectors, respectively.

 

 

 

CONESTOGA FUNDS

NOTES TO SCHEDULES OF INVESTMENTS (Continued)

 

5.Affiliated Issuers

 

A company is considered an affiliate of a Fund under the Investment Company Act of 1940 if the Fund’s holdings in that company represent 5% or more of the outstanding voting shares of that company. As of September 30, 2017, Exa Corporation was an affiliate of Conestoga Small Cap Fund but as of June 30, 2018 is no longer an affiliate of the Fund. As of June 30, 2018, Conestoga Small Cap Fund owns 5.23%, 8.30%, 5.82% and 5.93% of the outstanding voting shares of LeMaitre Vascular, Inc., Mesa Laboratories, Inc., NVE Corporation and Westwood Holdings Group, Inc., respectively. The industry and percentage of net assets for these holdings can be found on Conestoga Small Cap Fund’s Schedule of Investments. Further information on these holdings for the 9 months ended June 30, 2018 appears below:

 

Conestoga Small Cap Fund
From September 30, 2017 To June 30, 2018
   Exa
Corporation		   LeMaitre
Vascular, Inc.		   Mesa
Laboratories,
Inc.		 
Percentage of Outstanding Voting Shares Owned   0.00%   5.23%   8.30%
Shares at Beginning of Period   947,433    560,699    230,386 
Shares Purchased During the Period   -    449,600    76,950 
Shares Sold During the Period   (947,433)   -    - 
Shares at End of Period   -    1,010,299    307,336 
Value at Beginning of Period  $22,908,930   $20,981,357   $34,401,238 
Cost of Shares Purchased During the Period   -    15,368,089    11,544,564 
Cost of Shares Sold During the Period   (12,403,838)   -    - 
Change in Unrealized Appreciation (Depreciation)   (10,505,092)   (2,524,636)   18,926,681 
Value at End of Period  $-   $33,824,810   $64,872,483 
Net Realized Gains During the Period  $10,478,259   $-   $- 
Dividend Income Earned During the Period  $-   $162,284   $129,689 

 

   NVE
Corporation		   Westwood
Holdings Group,
Inc.		 
Percentage of Outstanding Voting Shares Owned   5.82%   5.93%
Shares at Beginning of Period   188,450    388,471 
Shares Purchased During the Period   93,300    146,050 
Shares Sold During the Period   -    - 
Shares at End of Period   281,750    534,521 
Value at Beginning of Period  $14,881,896   $26,132,444 
Cost of Shares Purchased During the Period   8,480,256    9,339,264 
Cost of Shares Sold During the Period   -    - 
Change in Unrealized Appreciation (Depreciation)   10,949,363    (3,646,328)
Value at End of Period  $34,311,515   $31,825,380 
Net Realized Gains During the Period  $-   $- 
Dividend Income Earned During the Period  $695,550   $973,089 

 

 

 

Item 2.Controls and Procedures.

 

(a) Based on their evaluation of the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) as of a date within 90 days of the filing date of this report, the registrant’s principal executive officer and principal financial officer have concluded that such disclosure controls and procedures are reasonably designed and are operating effectively to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to them by others within those entities, particularly during the period in which this report is being prepared, and that such information is recorded, processed, summarized, and reported on a timely basis.

 

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the registrant’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 3.Exhibits.

File as exhibits as part of this Form a separate certification for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2(a)): Attached hereto

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant) Conestoga Funds    
       
By (Signature and Title)* /s/ William C. Martindale, Jr.  
    William C. Martindale, Jr., Chief Executive Officer  
       
Date July 19, 2018    
 
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
       
By (Signature and Title)* /s/ William C. Martindale, Jr.  
    William C. Martindale, Jr., Chief Executive Officer  
       
Date July 19, 2018    
       
By (Signature and Title)* /s/ Robert M. Mitchell  
    Robert M. Mitchell, Treasurer and Chief Financial Officer  
       
Date July 19, 2018    

 

*Print the name and title of each signing officer under his or her signature.